Lactobacillus Casei Shirota (LCS; Yakult) vs Placebo in patients with well-compensated cirrhosis: A double-blind, randomized controlled study

被引：0
|
作者：
Macnaughtan, Jane [1 ]
Lopez, Elisabet Garcia [2 ]
Lu, Winston [1 ]
Jones, Helen [1 ]
Sawhney, Rohit [1 ]
Marsden, Joanne [3 ]
Davies, Nathan [1 ]
Cox, I. Jane [4 ]
Wright, Gavin [5 ]
Thomas, Linda [6 ]
Mookerjee, Rajeshwar [1 ]
Jalan, Rajiv [1 ]
机构：
[1] UCL, ILDH, London, England
[2] EF CLIF, Barcelona, Spain
[3] Kings Coll Hosp London, London, England
[4] Inst Hepatol, London, England
[5] Basildon & Thurrock Univ Hosp NHS Fdn Trust, Basildon, Essex, England
[6] Yakult GB, Ruislip, Middx, England
来源：
HEPATOLOGY | 2017年 / 66卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
840
引用
收藏
页码：449A / 449A
页数：1
相关论文
共 50 条
  • [1] A randomized, double-blind, placebo-controlled trial of aldafermin in patients with NASH and compensated cirrhosis
    Rinella, Mary E.
    Lieu, Hsiao D.
    Kowdley, Kris V.
    Goodman, Zachary D.
    Alkhouri, Naim
    Lawitz, Eric
    Ratziu, Vlad
    Abdelmalek, Manal F.
    Wong, Vincent Wai-Sun
    Younes, Ziad H.
    Sheikh, Aasim M.
    Brannan, Donald
    Freilich, Bradley
    Membreno, Fernando
    Sinclair, Marie
    Melchor-Khan, Liza
    Sanyal, Arun J.
    Ling, Lei
    Harrison, Stephen A.
    HEPATOLOGY, 2024, 79 (03) : 674 - 689
  • [2] Probiotics for patients with compensated liver cirrhosis: A double-blind placebo-controlled study
    Pereg, David
    Kotliroff, Andy
    Gadoth, Natan
    Hadary, Ruth
    Lishner, Michael
    Kitay-Cohen, Yona
    NUTRITION, 2011, 27 (02) : 177 - 181
  • [3] A randomized, double-blind study to evaluate the safety and tolerability of KB174, a novel synthetic glycan, in patients with well-compensated cirrhosis
    Bhandari, Bal Raj
    Cehelsky, Jeffrey
    Zheng, Yan
    Wingertzahn, Mark
    Palma, Norma
    Mittleman, Robert S.
    JOURNAL OF HEPATOLOGY, 2020, 73 : S699 - S699
  • [4] Effects of zibotentan and dapagliflozin on patients with compensated cirrhosis: a randomized double-blind placebo controlled exploratory pilot study
    Garcia-Pagan, Juan Carlos
    Lotte Gluud, Lise
    Mandorfer, Mattias
    Schattenberg, Jorn M.
    De Gottardi, Andrea
    Berzigotti, Annalisa
    Ignacio Fortea, Jose
    Albillos, Agustin
    Alvarado-Tapias, Edilmar
    Berning, Marco
    Petryszyn, Pawel
    Lin, Min
    Ambery, Philip
    Bosch, Jaime
    Oscarsson, Jan
    Rockey, Don
    JOURNAL OF HEPATOLOGY, 2024, 80 : S238 - S239
  • [5] A RANDOMIZED, DOUBLE-BLIND STUDY TO EVALUATE THE SAFETY AND TOLERABILITY OF KB174, A NOVEL SYNTHETIC GLYCAN, IN PATIENTS WITH WELL-COMPENSATED CIRRHOSIS
    Bhandari, Bal R.
    Cehelsky, Jeffrey
    Zheng, Yan
    Palma, Norma A.
    Wingertzahn, Mark
    Mittleman, Robert S.
    GASTROENTEROLOGY, 2020, 158 (06) : S1465 - S1465
  • [6] The effect of probiotic Lactobacillus casei Shirota on knee osteoarthritis: a randomised double-blind, placebo-controlled clinical trial
    Lei, M.
    Guo, C.
    Wang, D.
    Zhang, C.
    Hua, L.
    BENEFICIAL MICROBES, 2017, 8 (05) : 697 - 703
  • [7] The probiotic Lactobacillus casei Shirota attenuates symptoms of vestibular migraine: a randomised placebo-controlled double-blind clinical trial
    Qi, X.
    Fan, G.
    Jia, H.
    BENEFICIAL MICROBES, 2020, 11 (05) : 469 - 476
  • [8] A randomized, double-blind, placebo-controlled phase IIa trial of efruxifermin for patients with compensated NASH cirrhosis
    Harrison, Stephen A.
    Ruane, Peter J.
    Freilich, Bradley
    Neff, Guy
    Patil, Rashmee
    Behling, Cynthia
    Hu, Chen
    Shringarpure, Reshma
    de Temple, Brittany
    Fong, Erica
    Tillman, Erik J.
    Rolph, Timothy
    Cheng, Andrew
    Yale, Kitty
    JHEP REPORTS, 2023, 5 (01)
  • [9] Oral administration of probiotic Lactobacillus casei Shirota relieves pain after single rib fracture: a randomized double-blind, placebo-controlled clinical trial
    Lei, Min
    Guo, Chunhua
    Wang, Yong
    Hua, Limei
    Xue, Sujuan
    Yu, Dan
    Zhang, Chunhua
    Wang, Dawei
    ASIA PACIFIC JOURNAL OF CLINICAL NUTRITION, 2018, 27 (06) : 1252 - 1257
  • [10] Oral administration of Lactobacillus casei Shirota improves recovery of hand functions after distal radius fracture among elder patients: a placebo-controlled, double-blind, and randomized trial
    Zhang, Chunhua
    Xue, Sujuan
    Wang, Yong
    Yu, Dan
    Hua, Limei
    Guo, Chunhua
    Wang, Dawei
    Lei, Min
    JOURNAL OF ORTHOPAEDIC SURGERY AND RESEARCH, 2019, 14 (01)
12345